WASHINGTON, DC - Energy and Commerce Committee Republican Leader Greg Walden (R-OR) made the following statement after the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration announced their new action plan for the safe importation of certain prescription drugs.
“When it comes to lowering drug prices, I’ve never seen a president more engaged than President Trump. We appreciate the Administration’s continued focus on lowering drug prices - from the White House, to Secretary Alex Azar, to Acting FDA Commissioner, Dr. Ned Sharpless. The U.S. drug supply chain is the gold standard and the FDA is charged with ensuring drug safety to protect the public health. We look forward to continuing our work with HHS and FDA as we explore these paths to lower drug prices for American consumers, while ensuring Americans can remain confident that the drugs they take are safe and effective," said Walden.